It is also possible that GLP-1 drugs can penetrate the blood-brain barrier and might aid in the clearance of beta-amyloid, the toxic protein that is a hallmark of Alzheimers disease
F., Fonseca, V., Mosenzon, O., Raz, I., Goldman, B., Idorn, T., von Scholten, B
Sin embargo, su evidencia en pacientes TR es limitada
By examining the CAS Content Collection, the largest human-curated repository of scientific information, we can identify not only the growth in overall research and patents related to GLP-1 and GIP receptor agonists, but also the co-occurrences of these drugs with conditions beyond type II diabetes and obesity
But what if this year you invested in something that actually changes how you feel every single day